Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks Investment Research • Sep 23, 2026

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment

I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also simplifies its business and boosts its valuation appeal as a short-stay surgical pure-play. I see significant upside from the $60B inpatient-to-outpatient migration, supported by robust practitioner recruitment and disciplined acquisition strategy.

Seeking Alpha • Sep 23, 2026

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health.

GlobeNewsWire • Sep 17, 2026

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares

The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.

The Motley Fool • Sep 3, 2026

Likely ETF & Stock Winners From July Jobs Report

Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.

Zacks Investment Research • Aug 11, 2026

Surgery Partners Q2 Earnings Call Highlights

Surgery Partners NASDAQ: SGRY reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its Idaho Falls market operations to Intermountain Health.

MarketBeat • Aug 10, 2026

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 10, 2026

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates

Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.

Zacks Investment Research • Aug 10, 2026

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research • Jul 30, 2026

Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

Surgery Partners, Inc. (NASDAQ:SGRY) stock is trading higher on Friday as the company announced a significant transaction involving the sale of its ownership interests in Idaho Falls facilities to Intermountain Health.

Benzinga • Jul 24, 2026